Knowlton is the Executive Chairperson, Co-Founder, and Co-CEO of GalenusRx. Knowlton was recently Chairperson, Founder, and CEO of Tabula Rasa HealthCare (TRHC), which he took public in 2016. Prior to TRHC, the previous largest company he led (CEO, Chair, Founder) was Hospice Pharmacia / excelleRx, which grew to $250mln revenue, and served >800 hospices programs and 85,000 hospice patients nationwide with medication management solutions. It was sold to a Fortune 500 company in 2005 for $269mln. It is now owned by Humana.
GalenusRx is the 11th he led over the past few decades. His companies employed >4,000 team members and he raised more than $750 mln building these businesses.
His board service includes Chair of the Board of the Evergreens Continuing Care Retirement Community; Founding board member of the Cooper Medical School of Rowan University; member of the boards for The Coriell Institute for Medical Research, Coriell Life Sciences, St Christopher’s Hospital for Children, the Settlement Music School, Samaritan Hospice & Palliative Care, and current Chair of the American Foundation for Pharmacy Education.
Dr. Knowlton has won numerous awards for leadership in pharmacy, business, and philanthropy in his career, including the 2003 & 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2016 Philadelphia Technology CEO of the year. He served as the national President of the American College of Apothecaries, President of the American Pharmacists Association for two terms, and President of the American Pharmacists Association Foundation. In 2015, he was awarded the Remington Honor Medal, which is pharmacy’s highest honor in the U.S.
Dr. Knowlton received his BSPharm, from Temple University School of Pharmacy, his MDiv from Princeton Theological Seminary, his PhD in Pharmacoeconomics from Univ Maryland, and his ScD (Hon) Univ of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s.
